Injectable GLP-1 Protocol
Clinician-supervised semaglutide or tirzepatide injections for sustainable weight management, prescribed online and shipped to your door.
Clinically proven to help patients lose 15-20% of body weight.
Once-weekly injection with licensed clinician review.
Cold-chain shipping from FDA-registered pharmacies.
If approved, ships from licensed pharmacy partners.
“GLP-1 therapy changed the way I approach metabolic health with my patients.”
Healthspan Holistic
Mechanism
How GLP-1s Work With Your Body
The Science Behind GLP-1
15-20%
Average body weight lost
STEP 1 & SURMOUNT-1
68 wks
Sustained weight loss
STEP 5, Nature Med 2022
20%
Fewer cardiovascular events
SELECT, NEJM 2023
Step 1
Choose Your Medication
Both are once-weekly injections, clinician-supervised. Select the molecule you want to pursue first.
Safety
Reviewed before treatment ships
Your licensed clinician will check eligibility, medications, and safety.
Clinician guidance from the start
BMI, goals, medications, health history, and state
availability are checked before prescribing.
Special circumstances may require caution
Pregnancy, MTC/MEN2, pancreatitis, severe GI disease,
or certain conditions may make treatment unsafe.
Side effects are planned for
Your clinician reviews nausea risk, bowel changes,
diabetes medications, and oral-medication timing.
Care path
Get Care in 3 Easy Steps
Online medical intake
Share your health history and goals in a secure online intake.
Clinician review
A licensed clinician reviews your prescription for medical fit.
Fulfillment + support
Your treatment is sent, with ongoing general and MD support.
Clinical quality
Third-Party Tested
Potency Testing
Confirms your medication contains exactly the right dose — nothing more, nothing less.
FAQ
Frequently Asked Questions
Next step
Start Your Weight Loss Journey
Get clinician-supervised care with proven medications, all from home. A licensed provider is ready to help you find the right path.
Backed by Peer-Reviewed Research
14.9% mean body weight reduction vs 2.4% placebo over 68 weeks
STEP 1, NEJM 2021
20% fewer major cardiovascular events, independent of weight loss
SELECT Trial, NEJM 2023
Up to 22.5% weight reduction with tirzepatide
SURMOUNT-1, NEJM 2022
15.2% weight loss sustained over 2 years of continuous treatment
STEP 5, Nature Med 2022
Disclaimer
The information provided is for educational purposes only and is not a substitute for professional medical advice. Prescription products require online medical intake and approval from a licensed clinician. Not all patients will qualify. Some compounded medications may not be reviewed or approved by the FDA but are prepared by FDA-registered, state-licensed pharmacies in accordance with applicable regulations. Individual results may vary.